Search Results - "DESANTES, K"

Refine Results
  1. 1
  2. 2

    Reduced intensity conditioning using intravenous busulfan, fludarabine and rabbit ATG for children with nonmalignant disorders and CML by HORN, B, BAXTER-LOWE, L.-A, ENGLERT, L, MCMILLAN, A, QUINN, M, DESANTES, K, COWAN, M

    Published in Bone marrow transplantation (Basingstoke) (01-02-2006)
    “…The major problems with busulfan/cyclophosphamide (Bu/Cy)-containing conditioning regimens are acute toxicities and graft failure. To decrease acute…”
    Get full text
    Journal Article
  3. 3

    An evaluation of engraftment, toxicity and busulfan concentration in children receiving bone marrow transplantation for leukemia or genetic disease by BOLINGER, A. M, ZANGWILL, A. B, SLATTERY, J. T, GLIDDEN, D, DESANTES, K, HEYN, L, RISLER, L. J, BOSTROM, B, COWAN, M. J

    Published in Bone marrow transplantation (Basingstoke) (01-05-2000)
    “…Autologous recovery is a major problem with busulfan as a marrow ablative agent in conditioning children for allogeneic BMT. Data suggest the average…”
    Get full text
    Journal Article
  4. 4

    Autoimmune hemolytic anemia in patients with SCID after T cell-depleted BM and PBSC transplantation by HORN, B, VIELE, M, MENTZER, W, MOGEK, N, DESANTES, K, COWAN, M

    Published in Bone marrow transplantation (Basingstoke) (01-11-1999)
    “…We report a high incidence (19.5%) of autoimmune hemolytic anemia (AIHA) in 41 patients with SCID who underwent a T cell-depleted haploidentical transplant…”
    Get full text
    Journal Article
  5. 5

    Treatment of refractory non-Hodgkin's lymphoma with radiolabeled MB-1 (anti-CD37) antibody by Press, O W, Eary, J F, Badger, C C, Martin, P J, Appelbaum, F R, Levy, R, Miller, R, Brown, S, Nelp, W B, Krohn, K A

    Published in Journal of clinical oncology (01-08-1989)
    “…The biodistribution, toxicity, and therapeutic potential of anti-CD37 monoclonal antibody (MoAb) MB-1 labeled with iodine 131 (131I) was evaluated in ten…”
    Get more information
    Journal Article
  6. 6
  7. 7
  8. 8

    Phase I dose escalation of 131I-metaiodobenzylguanidine with autologous bone marrow support in refractory neuroblastoma by Matthay, K K, DeSantes, K, Hasegawa, B, Huberty, J, Hattner, R S, Ablin, A, Reynolds, C P, Seeger, R C, Weinberg, V K, Price, D

    Published in Journal of clinical oncology (01-01-1998)
    “…The analogue 131I-metaiodobenzylguanidine (MIBG), which is specifically targeted to neuroblastoma cells, may provide more effective and less toxic treatment…”
    Get more information
    Journal Article
  9. 9

    Phase I study of fenretinide (4-HPR) oral powder in patients with recurrent or resistant neuroblastoma: New Approaches to Neuroblastoma Therapy (NANT) Consortium trial by Marachelian, A., Kang, M. H., Hwang, K., Villablanca, J. G., Groshen, S., Matthay, K. K., Maris, J., DeSantes, K. B., Reynolds, C. P., Maurer, B. J.

    Published in Journal of clinical oncology (20-05-2009)
    “…Abstract only 10009 Background: Fenretinide (4-HPR), a cytotoxic retinoid, achieved limited and variable plasma levels when tested in a corn oil-based capsule…”
    Get full text
    Journal Article
  10. 10

    Pleasant memories: remembering immune protection while forgetting about graft-versus-host disease by Sondel, P. M.

    Published in The Journal of clinical investigation (01-07-2003)
    “…Graft-versus-host disease (GVHD) represents a major cause of morbidity and mortality following conventional allogeneic hematopoietic stem cell transplantation…”
    Get full text
    Journal Article
  11. 11

    Bone marrow transplantation for T-B- severe combined immunodeficiency disease in Athabascan-speaking native Americans by O'MARCAIGH, A. S, DESANTES, K, HU, D, PABST, H, HORN, B, LI, L, COWAN, M. J

    Published in Bone marrow transplantation (Basingstoke) (01-04-2001)
    “…A distinct form of autosomal recessive T-B- severe combined immunodeficiency disease occurs with a high frequency among Athabascan-speaking Native Americans…”
    Get full text
    Journal Article
  12. 12

    Cognitive and adaptive behavior 1 and 3 years following bone marrow transplantation by Kramer, J H, Crittenden, M R, DeSantes, K, Cowan, M J

    Published in Bone marrow transplantation (Basingstoke) (01-03-1997)
    “…Children receiving a bone marrow transplant (BMT) are at risk for neuropsychological late effects because of potentially neurotoxic chemotherapy and total body…”
    Get full text
    Journal Article
  13. 13

    Radiolabeled antibody targeting of the HER-2/neu oncoprotein by DE SANTES, K, SLAMON, D, ANDERSON, S. K, SHEPARD, M, FENDLY, B, MANEVAL, D, PRESS, O

    Published in Cancer research (Baltimore) (01-04-1992)
    “…The HER-2/neu oncogene encodes a Mr 185,000 transmembrane phosphoglycoprotein which is overexpressed in 25-35% of breast and ovarian neoplasms and portends a…”
    Get full text
    Conference Proceeding Journal Article
  14. 14
  15. 15

    Bone marrow transplantation for T super(-)B super(-) severe combined immunodeficiency disease in Athabascan-speaking native Americans by O'Marcaigh, A S, DeSantes, K, Hu, D, Pabst, H, Horn, B, Li, L, Cowan, MJ

    Published in Bone marrow transplantation (Basingstoke) (01-04-2001)
    “…A distinct form of autosomal recessive T super(-)B super(-) severe combined immunodeficiency disease occurs with a high frequency among Athabascan-speaking…”
    Get full text
    Journal Article
  16. 16

    Bone marrow transplantation in Fanconi anemia using matched sibling donors by Kohli-Kumar, M, Morris, C, DeLaat, C, Sambrano, J, Masterson, M, Mueller, R, Shahidi, N T, Yanik, G, Desantes, K, Friedman, D J

    Published in Blood (15-09-1994)
    “…Eighteen patients with Fanconi anemia (FA) with evidence of bone marrow (BM) aplasia underwent allogenic BM transplants (BMT) from matched sibling donors…”
    Get full text
    Journal Article
  17. 17
  18. 18
  19. 19

    Maternal mosaicism for a novel interleukin-2 receptor γ-chain mutation causing X-linked severe combined immunodeficiency in a Navajo kindred by O'MARCAIGH, A. S, PUCK, J. M, PEPPER, A. E, DE SANTES, K, COWAN, M. J

    Published in Journal of clinical immunology (1997)
    “…X-linked severe combined immunodeficiency disease (SCID) results from mutations of IL2RG, the gene encoding the interleukin-2 receptor gamma chain, also known…”
    Get full text
    Journal Article
  20. 20

    Inhibition of catabolism of radiolabeled antibodies by tumor cells using lysosomotropic amines and carboxylic ionophores by PRESS, O. W, DE SANTES, K, ANDERSON, S. K, GEISSLER, F

    Published in Cancer research (Chicago, Ill.) (15-02-1990)
    “…The rates of degradation of radioiodinated monoclonal antibodies (MoAbs) by malignant T- and B-lymphoid cells were studied in the presence and absence of a…”
    Get full text
    Journal Article